Wilson-Konovalov disease in 3 sisters: A radical change in prognosis if timely diagnosed
- Authors: Rozina TP1,2, Ignatova TM1,3, Solov'eva OV1
-
Affiliations:
- Первый МГМУ им. И.М. Сеченова
- МГУ им. М.В. Ломоносова
- ФГБУ "Научно-исследовательский институт ревматологии им. В.А. Насоновой" РАМН
- Issue: Vol 86, No 4 (2014)
- Pages: 80-84
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31506
- ID: 31506
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
T P Rozina
Первый МГМУ им. И.М. Сеченова; МГУ им. М.В. Ломоносова
Email: alrozin@yandex.ru
T M Ignatova
Первый МГМУ им. И.М. Сеченова; ФГБУ "Научно-исследовательский институт ревматологии им. В.А. Насоновой" РАМН
O V Solov'eva
Первый МГМУ им. И.М. Сеченова
References
- Wilson S.A.K. Hepatolenticular degeneration and cirrosis. Brain 1912; 34:295-509.
- Wilson S.A.K. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Lancet 1912; 1:1115-1119.
- Коновалов Н.В. Гепатоцеребральная дистрофия. М 1960.
- Walshe J.M. Penicillamine, a new oral therapy for Wilson’s disease. Am J Med 1956; 21: 487-492.
- Ferenci P. Wilson’s disease. Clinical Gastroenterology and Hepatology 2005; 3: 726-733.
- Gitlin J.D. Wilson disease. Gastroenterology 2003; 125: 1868-1877.
- Gollan J.L., Gollan J.G. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28: 28-36.
- Roberts E.A., Schilsky M.L. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47 (6): 2089-2111.
- Steindl P., Ferenci P., Dienes H.P. et al. Wilson’s disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997; 113: 212-218.
- Brewer G.J., Yuzbasiyan-Gurcan V. Wilson disease. Medicine 1992; 71 (3): 139-164.
- Gow P.J., Smallwood R.A., Angus P.W. et al. Diagnosis of Wilson’s disease: an experience over three decades. Gut 2000; 46: 415-419.
- Розина Т.П., Рахимова О.Ю., Лопаткина Т.Н. Клиническая характеристика, течение и прогноз абдоминальной формы болезни Вильсона-Коновалова. Рос журн гастроэнтерол, гепатол, колопроктол 2005; 4: 5.
- Berman D.H., Leventhal R.I., Gavaler J.S. et al. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991; 100: 1129-1134.
- Kiss J.E., Berman D., Van Thiel D. Effective removal of copper by plasma exchange in fulminant Wilson’s disease. Transfusion 1998; 38: 327-331.
- Sen S., Felldin M., Steiner C., Larsson B. Albumin dialysis and Molecular Adsorbents Recirculating system (MARS) for acute Wilson’s disease. Liver Transpl 2002; 8 (10): 962-967.
- Korman J.D., Volenberg I., Balko J. et al. Pediatric and Adult Acute Liver Failure Study Groups, Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests, Hepatology 2008; 48: 1167-1174.
- Merle U., Schaefer M., Ferenci P., Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study. Gut 2007; 56: 115-120.
- Игнатова Т.М., Ильина Н.А., Потапова А.В., Юсов С.П., Попова И.В. Висцеральные проявления болезни Вильсона-Коновалова (анализ 22 наблюдений). Клин мед 1995; 6: 23-26.
- Schilsky M.L. Diagnosis and treatment of Wilson’s disease. Pediatr Transplant 2002; 6: 15-19.
- Lang C.J., Rabas-Kolominsky P., Engelhardt A. et al. Fatal deterioration of Wilson’s disease after institution of oral zinc therapy. Arch Neurol 1993; 50: 1007-1008.
- Walshe J.M., Munro N.A. Zinc-induced deterioration in Wilson’s disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet. Arch Neurol 1995; 52: 10-11.
Supplementary files
